News tagged with hematology
(Medical Xpress) -- Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells, a team of UCLA researchers have now demonstrated ...
HIV & AIDS Apr 12, 2012 | 4.8 / 5 (64) | 0 |
(HealthDay)—The new anti-clotting drug apixaban (Eliquis) appears to help prevent potentially fatal blood clots in patients with deep vein thrombosis (DVT), a new Italian study finds.
Medications Dec 10, 2012 | 5 / 5 (3) | 0 |
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell ...
Cancer May 13, 2013 | 5 / 5 (3) | 0 |
Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenstrom's macroglobulinemia, a rare form of lymphoma that has eluded all previous ...
Cancer Dec 12, 2011 | 5 / 5 (2) | 0
(Medical Xpress) -- The future of prostate cancer therapy may lie in a tiny, "sticky" silicon chip dubbed GEDI (Geometrically Enhanced Differential Immunocapture, pronounced like the "Star Wars" forces of ...
Cancer Jun 28, 2012 | 5 / 5 (2) | 0 |
Researchers at Winship Cancer Institute of Emory University have identified a new function for a gene that normally prevents the development of cancer.
Cancer Mar 01, 2012 | 4 / 5 (2) | 0 |
An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other ...
Cancer Dec 11, 2011 | 3.5 / 5 (2) | 0
Newly diagnosed cancer patients frequently face hurdles in obtaining an appointment for care with an oncologist, according to new research from the Perelman School of Medicine at the University of Pennnsylvania that will ...
Cancer Jun 01, 2011 | 5 / 5 (1) | 1
An interim analysis of a phase II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated both in patients who are undergoing treatment for the first ...
Cancer Jun 06, 2011 | 5 / 5 (1) | 0 |
While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment.
Cancer Aug 17, 2011 | 5 / 5 (1) | 0 |
For the first time, researchers have successfully injected cultured red blood cells (cRBCs) created from human hematopoietic stem cells (HSCs) into a human donor, according to study results published today in Blood, the Journal of the American Society of Hematology (ASH). As the ...
Medical research Sep 01, 2011 | 5 / 5 (1) | 0 |
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of ...
Cancer Dec 11, 2011 | 5 / 5 (1) | 0
A new treatment using leukemia patients' own infection-fighting cells appears to protect them from infections and cancer recurrence following treatment with fludarabine-based chemotherapy, according to new research from the ...
Cancer Dec 12, 2011 | 5 / 5 (1) | 0 |
those disc-shaped cells circulating in your blood -- rush to the scene, clumping together to plug the leak.
Medical research May 03, 2012 | 5 / 5 (1) | 0 |
Patients with type 2 diabetes have a 20 percent increased risk of developing blood cancers, such as non-Hodgkin lymphoma, leukemia and myeloma, according to a new meta-analysis led by researchers at The Miriam Hospital. The ...
Cancer Jun 05, 2012 | 5 / 5 (1) | 0 |
Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases. The lab work that goes into the study of blood is performed by a medical technologist.
Blood diseases affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, the mechanism of coagulation, etc.
Physicians specialized in hematology are known as hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the haematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various haematological test results. In some institutions, haematologists also manage the haematology laboratory. Physicians who work in haematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of haematological diseases, referred to as haematopathologists. Haematologists and haematopathologists generally work in conjunction to formulate a diagnosis and deliver the most appropriate therapy if needed. Haematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology. Haematologists may specialise further or have special interests, for example in:
only some blood disorders can be cured.
(Hematology comes from the Greek words ἁίμα (haima) meaning "blood" and λόγος (logos), a root commonly employed to denote a field of study.)
For more information about Hematology, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.